Shiv Nadar to invest $500 million in the US healthcare space

Published On 2015-09-14 10:29 GMT   |   Update On 2015-09-14 10:29 GMT
In order to rev up the online healthcare space in the US market, Shiv Nadar, Managing Director of HCL Tech in partnership with Sanjay Kalra, ex Tech Mahindra CEO, will make an investment of $500 million in the IT health products/platforms to offer accessible healthcare service in the US.

Confirming this news to cnbc tv18, the two business honchos spoke about their newly launched investment firm, and how they are planning to capture the expanded healthcare space in the US under the initiative of ‘ObamaCare’. US healthcare IT space is 16 percent or 17 percent of the US gross domestic product (GDP), which is almost worth USD 3.2 trillion. With the new affordable act being introduced by Obama under his presidentship, the US market is reported to be flooded with opportunities to invest in the online healthcare space.

The investment plan to be followed by Shiv Nadar is to invest in matured companies in the US, to be able to have an instant business connect by acquiring established products, talent and services in the online market in the US. Thereafter, the business duo will invest in startup’s and innovative companies to create an integrated portfolio, with a huge sum of $500 million earmarked clearly for the medium term timeframe.

The multi-million dollar investments is also reported at including solutions spanning this whole continuum which could be right from customer engagement, going down to revenue cycle management, supply chain management and clinical management.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News